The Board has remanded the case for further development, including obtaining SSA records and VA treatment records. A VA examination is also required to determine the nature, extent, and etiology of the Veteran's claimed splenomegaly and pancytopenia.
The deciding factor: Further development is needed as directed by the Board to obtain necessary medical records and for a VA examination.
- Claimed conditions
- leukopenia, splenomegaly, pancytopenia
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- August 12, 2014
- Citation
- 1435970
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1435970.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has granted service connection for hepatitis C and its secondary effects on other conditions, including cirrhosis of the liver, diabetes mellitus type II, esophageal varices, hepatic encephalopathy, and splenomegaly.
- Whole decision: Remanded (sent back)
The Veteran's claim for service connection for a blood/bone marrow disorder, including myelodysplastic syndrome, leukopenia, and neutropenia, is being remanded due to the submission of new and relevant evidence. The Board acknowledges that the Veteran was exposed to Agent Orange during his military service in Vietnam.
- Whole decision: Remanded (sent back)
The Board has remanded the case due to insufficient information regarding the Veteran's exposure to herbicide agents and other environmental hazards during service, as well as a need for a toxic exposure risk activity (TERA) memorandum and opinion.
- Whole decision: Denied
The Veteran's leukopenia has not required continuous medication for control or intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/l, and therefore does not meet the criteria for a compensable rating.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.